Adam Havey

2021

In 2021, Adam Havey earned a total compensation of $2.1M as Executive Vice Presidentand Chief Operating Officer at Emergent BioSolutions, a 4% decrease compared to previous year.

Compensation breakdown

Non-Equity Incentive Plan$261,405
Option Awards$549,630
Salary$574,270
Stock Awards$700,054
Other$7,425
Total$2,092,783

Havey received $700.1K in stock awards, accounting for 33% of the total pay in 2021.

Havey also received $261.4K in non-equity incentive plan, $549.6K in option awards, $574.3K in salary and $7.4K in other compensation.

Rankings

In 2021, Adam Havey's compensation ranked 5,876th out of 12,415 executives tracked by ExecPay. In other words, Havey earned more than 52.7% of executives.

ClassificationRankingPercentile
All
5,876
out of 12,415
53rd
Division
Manufacturing
2,484
out of 5,505
55th
Major group
Chemicals And Allied Products
1,077
out of 2,375
55th
Industry group
Drugs
958
out of 2,096
54th
Industry
Pharmaceutical Preparations
688
out of 1,546
56th

Pay ratio

Adam Havey's Pay$2,092,783
Median Employee's Pay$110,416
Pay Ratio

19

to 1

In 2021, the annual total compensation of Adam Havey was $2,092,783.

The annual total compensation of the median employee at Emergent BioSolutions was $110,416.

The ratio of Adam Havey's pay to the pay of median employee was therefore 19 to one.

Source: SEC filing on April 15, 2022.

Havey's colleagues

We found four more compensation records of executives who worked with Adam Havey at Emergent BioSolutions in 2021.

2021

Robert Kramer

Emergent BioSolutions

Chief Executive Officer

2021

Fuad El-Hibri

Emergent BioSolutions

Chairman

2021

Richard Lindahl

Emergent BioSolutions

Chief Financial Officer

2021

Atul Saran

Emergent BioSolutions

Executive Vice Presidentand Chief Strategy andand Development Officer

News

You may also like